Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 27,500 shares at $0.43 ($12K) on 2022-11-02, disclosed to the SEC on 2022-11-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 7,500 | $3K | 28.2% |
| 2 | $0.43 | 5,000 | $2K | 18.0% |
| 3 | $0.43 | 15,000 | $6K | 53.9% |
| Total | $0.44 avg | 27,500 | $12K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |
| EMMA | BUY | 2022-10-17 | $17K | — | Filing → |